The forward 4-quarter S&P 500 EPS estimate fell to $271.24 this week, after last week’s $273.33 and the prior week’s $273.17.

Trump spoke to reporters in a press conference with Japanese Prime Minister Shigeru Ishiba. When asked whether he would ...

ING Groep N.V.'s shares underperform in the European financials space, despite solid core capital returns and dividends.

Learn about the significant risks facing the U.S. economy, including mounting debt and geopolitical tensions, and the ...

Altria Group's EBT multiple is only 7.5x with a 13.3% yield, making it comparable to an equity bond in some ways. Click here ...

Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.

Financial writer recommends buy rating for Infineon (IFNNY) citing strong AI growth potential and attractive valuation in ...

JinkoSolar is a buy with strong operational efficiency and resilience in the solar market, bolstered by strategic ...

Discover the successful decade-long journey of a stock portfolio focusing on dividend growth companies, outperforming the S&P ...

Palantir's key contracts like the Army Vantage extension and TITAN system will benefit the tech giant for some time. Read ...

Equinor ASA shows strong earnings and growth projections for 2025, with a focus on sustainable energy and potential risks.

Financial writer discusses Coya Therapeutics, Inc.'s Treg therapies for neurodegenerative diseases like ALS, FTD, and PD.